Epidemiology of hepatitis E in pregnant women and children in Iran: A general overview

Journal of Clinical and Translational Hepatology

Volumn 4, Issue 3, 2016, Pages 269-276

  Taherkhani, Reza ^a   Farshadpour, Fatemeh ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Children; Epidemiology; Hepatitis E virus; Iran; Pregnant women

Indexed keywords

EID: 85022029280     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2016.00013     Document Type: Review

References (85)

1. Pérez-Gracia MT, García M, Suay B, Mateos-Lindemann ML. Current Knowledge on Hepatitis E. J Clin Transl Hepatol 2015;3:117–126. doi: 10.14218/JCTH.2015.00009.
2. Taherkhani R, Farshadpour F, Makvandi M, Rajabi Memari H, Samarbafzadeh AR, Sharifi N, et al. Cytokine profiles and cell proliferation responses to truncated ORF2 protein in Iranian patients recovered from hepatitis E infection. J Trop Med 2015;2015:523560. doi: 10.1155/2015/523560.
3. Sridhar S, Lau SK, Woo PC. Hepatitis E: A disease of reemerging importance. J Formos Med Assoc 2015;114:681–690. doi: 10.1016/j.jfma.2015.02.003.
4. Bajpai M, Gupta E. Transfusion-transmitted hepatitis E: is screening war-ranted? Indian J Med Microbiol 2011;29:353–358. doi: 10.4103/0255-0857.90158.
5. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014;27:116–138. doi: 10.1128/CMR.00057-13.
6. Rockville M. Topic I: Hepatitis E virus (HEV) and blood transfusion safety blood products advisory committee, 104th Meeting, September 20, 2012. FDA Fishers Lane Building 5630 Fishers Lane, Room 1066. 2012:1–24.
7. Pischke S, Behrendt P, Bock CT, Jilg W, Manns MP, Wedemeyer H. Hepatitis E in Germany–an under-reported infectious disease. Dtsch Arztebl Int 2014; 111:577–583. doi: 10.3238/arztebl.2014.0577.
8. Fujiwara S, Yokokawa Y, Morino K, Hayasaka K, Kawabata M, Shimizu T. Chronic hepatitis E: a review of the literature. J Viral Hepat 2014;21:78–89. doi: 10.1111/jvh.12156.
9. Lapa D, Capobianchi MR, Garbuglia AR. Epidemiology of hepatitis E virus in European countries. Int J Mol Sci 2015;16:25711–25743. doi: 10.3390/ijms161025711.
10. Hosseini Moghaddam SM. Hepatitis E virus and renal transplantation. Hepat Mon 2011;11:599–600. doi: 10.5812/kowsar.1735143X.
11. Kamar N. Hepatitis e virus infection in Iranian kidney-transplant patients. Hepat Mon 2011;11:927–928. doi: 10.5812/kowsar.1735143X.
12. Fierro NA, Realpe M, Meraz-Medina T, Roman S, Panduro A. Hepatitis E virus: An ancient hidden enemy in Latin America. World J Gastroenterol 2016;22: 2271–2283. doi: 10.3748/wjg.v22.i7.2271.
13. Shrestha AC, Faddy HM, Flower RL, Seed CR, Keller AJ. Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history? Pathology 2015; 47:97–100. doi: 10.1097/PAT.0000000000000229.
14. Taherkhani R, Farshadpour F. Epidemiology of hepatitis E virus in Iran. World J Gastroenterol 2016;22:5143–5153. doi: 10.3748/wjg.v22.i22.5143.
15. Bazerbachi F, Haffar S, Garg SK, Lake JR. Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the lit-erature. Gastroenterol Rep (Oxf) 2016;4:1–15. doi: 10.1093/gastro/gov042.
16. Kim JH, Nelson KE, Panzner U, Kasture Y, Labrique AB, Wierzba TF. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis 2014;14:308. doi: 10.1186/1471-2334-14-308.
17. Marano G, Vaglio S, Pupella S, Facco G, Bianchi M, Calizzani G, et al. Hepatitis E: an old infection with new implications. Blood Transfus 2015;13:6–17. doi: 10.2450/2014.0063-14.
18. Taherkhani R, Farshadpour F. A new strategy for development of hepatitis E vaccine: Epitope-based vaccines. Pathog Infect Dis 2015;1:e933.
19. World Health Organization. Hepatitis E, WHO fact sheet; No. 280, updated July 2015. Available at: http://www.who.int/mediacentre/factsheets/fs280/en.
20. World Health Organization. Viral hepatitis report by the Secretariat; A62/22. Available at: apps.who.int/gb/ebwha/pdf_files/A62/A62_22-en.pdf.
21. Khuroo MS, Khuroo MS. Hepatitis E: an emerging global disease-from discovery towards control and cure. J Viral Hepat 2016;23:68–79. doi: 10. 1111/jvh.12445.
22. Teshale EH, Hu DJ. Hepatitis E: Epidemiology and prevention. World J Hepatol 2011;3:285–291. doi: 10.4254/wjh.v3.i12.285.
23. Tian DY, Chen Y, Xia NS. Significance of serum IgA in patients with acute hepatitis E virus infection. World J Gastroenterol 2006;12:3919–3923. doi: 10.3748/wjg.v12.i24.3919.
24. Farshadpour F, Taherkhani R, Makvandi M, Rajabi Memari H, Samarbafzadeh AR. Codon-optimized expression and purification of truncated ORF2 protein of hepatitis E virus in escherichia coli. Jundishapur J Microbiol 2014;7: e11261. doi: 10.5812/jjm.
25. Wang L, Zhuang H. Hepatitis E: an overview and recent advances in vaccine research. World J Gastroenterol 2004;10:2157–2162.
26. Lee GY, Poovorawan K, Intharasongkroh D, Sa-Nguanmoo P, Vongpunsawad S, Chirathaworn C, et al. Hepatitis E virus infection: Epidemiology and treatment implications. World J Virol 2015;4:343–355.10.5501/wjv.v4.i4.343.
27. Verghese VP, Robinson JL. A systematic review of hepatitis E virus infection in children. Clin Infect Dis 2014;59:689–697. doi: 10.1093/cid/ciu371.
28. Farshadpour F, Makvandi M, Taherkhani R. Design, construction and cloning of truncated ORF2 and tPAsp-PADRE-truncated ORF2 gene cassette from hepatitis E virus in the pVAX1 expression vector. Jundishapur J Microbiol 2015;8:e26035. doi: 10.5812/jjm.
29. Ahmed A, Ali IA, Ghazal H, Fazili J, Nusrat S. Mystery of hepatitis E virus: recent advances in its diagnosis and management. Int J Hepatol 2015;2015: 872431. doi: 10.1155/2015/872431.
30. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diag-nosis, transmission, epidemiology, and prevention. J Med Virol 2008;80: 646–658. doi: 10.1002/jmv.21116.
31. Yazbek S, Kreidieh K, Ramia S. Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety. Infection 2016;44:11–22. doi: 10.1007/s15010-015-0807-5.
32. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698–709. doi: 10.1016/S1473-3099(08)70255-X.
33. Sayed IM, Vercauteren K, Abdelwahab SF, Meuleman P. The emergence of hepatitis E virus in Europe. Future Virology 2015;10:763–778. doi: 10.2217/fvl.15.29.
34. Jamali R. Epidemiologic studies on viral hepatitis: a short review. Thrita 2014;3:e15376. doi: 10.5812/thrita.15376.
35. Farshadpour F, Taherkhani R, Makvandi M. Prevalence of hepatitis E virus among adults in south-west of Iran. Hepat Res Treat 2015;2015:759589. doi: 10.1155/2015/759589.
36. Ahmadi Ghezeldasht S, Miri R, Hedayatimoghadam M, Shamsian A, Bidkhori H, Fathimoghadam F, et al. Population movement and virus spreading: HEV spreading in a Pilgrimage city, Mashhad in northeast Iran; an example. Hepat Mon 2013;13:e10255. doi: 10.5812/hepatmon.10255.
37. Chaudhry SA, Verma N, Koren G. Hepatitis E infection during pregnancy. Can Fam Physician 2015;61:607–608.
38. El Sayed Zaki M, El Razek MM, El Razek HM. Maternal-fetal hepatitis E trans-mission: is it underestimated? J Clin Transl Hepatol 2014;2:117–123. doi: 10.14218/JCTH.2014.00006.
39. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: under-standing the pathogenesis. Liver Int 2008;28:1190–1199. doi: 10.1111/j. 1478-3231.2008.01840.x.
40. Kumar A, Begum N. Hepatitis E in pregnancy: an insight into etiopathogen-esis. JIMSA 2010;23:281–283.
41. Taherkhani R, Makvandi M, Farshadpour F. Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virus. Ann Lab Med 2014;34:118–126. doi: 10.3343/alm.2014.34.2.118.
42. Kar P. Hepatitis E virus infection during pregnancy: why is the disease stormy? Medicine Update 2012;22:459–462.
43. Bernuau J, Nicand E, Durand F. Hepatitis E-associated acute liver failure in pregnancy: an Indian puzzle. Hepatology 2008;48:1380–1382. doi: 10. 1002/hep.22619.
44. Navaneethan U. Seroprevalence of hepatitis E infection in pregnancy-more questions than answers. Indian J Med Res 2009;130:677–679.
45. Rostamzadeh Khameneh Z, Sepehrvand N, Khalkhali HR. Seroprevalence of hepatitis E among pregnant women in Urmia, Iran. Hepat Mon 2013;13: e10931. doi: 10.5812/hepatmon.10931.
46. Rasti M, Samarbafzadeh A, Neisi N, Makvandi M, Najafifard S, Sharifat M, et al. Study on the seroprevalence of hepatitis E virus infection in pregnant women referring to Imam Khomeini general hospital in Ahvaz. Jentashapir J Health Res 2014;5:101–105.
47. Mamani M, Zamani M, Hashemi SH, Keramat F. Seroprevalence of antibodies to hepatitis E virus among pregnant women. Avicenna J Clin Microbiol Infect 2015;2:e25339. doi: 10.17795/ajcmi-25339.
48. Tabarraei A, Moradi A, Rodgari D, Javid N, Bakhshandeh Nosrat S. Anti-hepatitis E virus seroprevalence in pregnant women, in Gorgan, Iran, North East of Caspian Sea. International Conference on Life Science and Technology, Singapore 2011.
49. Moradi A, Besharat S, Minaiifar MM, Roshandel G, Tabaraii A. Seroepidemio-logic assessment of hepatitis E virus in women of reproductive age, Gorgan. Zahedan J Res Med Sci 2010;12:44–47.
50. Begum N, Devi SG, Husain SA, Ashok K, Kar P. Seroprevalence of subclinical HEV infection in pregnant women from north India: a hospital based study. Indian J Med Res 2009;130:709–713.
51. Stoszek SK, Abdel-Hamid M, Saleh DA, El Kafrawy S, Narooz S, Hawash Y, et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006;100:95–101. doi: 10.1016/j.trstmh.2004. 12.005.
52. Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, et al. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J 2009;6:108. doi: 10.1186/1743-422X-6-108.
53. Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001;100:9–15. doi: 10.1016/S0301-2115(01)00448-1.
54. Oncu S, Oncu S, Okyay P, Ertug S, Sakarya S. Prevalence and risk factors for HEV infection in pregnant women. Med Sci Monit 2006;12:CR36–39.
55. Saffar MJ, Farhadi R, Ajami A, Khalilian AR, Babamahmodi F, Saffar H. Seroe-pidemiology of hepatitis E virus infection in 2–25-year-olds in Sari district, Islamic Republic of Iran. East Mediterr Health J 2009;15:136–142.
56. Shamsizadeh A, Nikfar R, Makvandi M, Shamsizadeh N. Seroprevalence of hepatitis E virus infection in children in the Southwest of Iran. Hepat Mon 2009;9:261–264.
57. Reza Sharif A, Reza Sharif M, Taghavi Ardekani A, Madani M, Kheirkhah D, Afzali H. Seroepidemiology of hepatitis E in children of Kashan, 2012. Iranian J Infect Dis Trop Med 2014;18:31–36.
58. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan Province: a population-based study. Int J Infect Dis 2009;13:67–71. doi: 10.1016/j.ijid.2008.03.030.
59. Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi MA. Seroprevalence of hepatitis A and E virus infections among healthy population in Shiraz, Southern Iran. Jundishapur J Microbiol 2015;8:e19311. doi: 10.5812/jjm. 19311v2.
60. Fix AD, Abdel-Hamid M, Purcell RH, Shehata MH, Abdel-Aziz F, Mikhail N, et al. Prevalence of antibodies to hepatitis E in two rural Egyptian commun-ities. Am J Trop Med Hyg 2000;62:519–523.
61. Taremi M, Mohammad Alizadeh AH, Ardalan A, Ansari S, Zali MR. Seropreva-lence of hepatitis E in Nahavand, Islamic Republic of Iran: a population-based study. East Mediterr Health J 2008;14:157–162.
62. Teshale EH, Hu DJ, Holmberg SD. The two faces of hepatitis E virus. Clin Infect Dis 2010;51:328–334. doi: 10.1086/653943.
63. Vasickova P, Psikal I, Kralik P, Widen F, Hubalek Z, Pavlik I. Hepatitis E virus: a review. Veterinarni Medicina 2007;52:365–384.
64. Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2013; 10:24–33. doi: 10.1038/nrgastro.2012.187.
65. Dreier J, Juhl D. Autochthonous hepatitis e virus infections: a new transfusion-associated risk? Transfus Med Hemother 2014;41:29–39. doi: 10.1159/000357098.
66. Shahzad F, Atiq M, Ejaz S, Hameed S. Hepatitis E: review of a disease endemic in Pakistan. J Pak Med Assoc 2001;51:166–169.
67. Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005;23:2893–2901. doi: 10.1016/j.vaccine.2004.11.064.
68. Purdy MA, McCaustland KA, Krawczynski K, Tam A, Beach MJ, Tassopoulos NC, et al. Expression of a hepatitis E virus (HEV)-trpE fusion protein contain-ing epitopes recognized by antibodies in sera from human cases and exper-imentally infected primates. Arch Virol 1992;123:335–349. doi: 10.1007/BF01317268.
69. Robinson RA, Burgess WH, Emerson SU, Leibowitz RS, Sosnovtseva SA, Tsarev S, et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif 1998; 12:75–84. doi: 10.1006/prep.1997.0817.
70. Zhang JZ, Ng MH, Xia NS, Lau SH, Che XY, Chau TN, et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol 2001;64:125–132. doi: 10.1002/jmv.1027.
71. Li TC, Takeda N, Miyamura T, Matsuura Y, Wang JC, Engvall H, et al. Essential elements of the capsid protein for self-assembly into empty virus-like par-ticles of hepatitis E virus. J Virol 2005;79:12999–13006. doi: 10.1128/JVI. 79.20.12999-13006.2005.
72. McAtee CP, Zhang Y, Yarbough PO, Fuerst TR, Stone KL, Samander S, et al. Purification and characterization of a recombinant hepatitis E protein vaccine candidate by liquid chromatography-mass spectrometry. J Chromatogr B Biomed Appl 1996;685:91–104. doi: 10.1016/0378-4347(96)00143-0.
73. Huang WJ, Zhang HY, Harrison TJ, Lan HY, Huang GY, Wang YC. Immunoge-nicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4. Arch Virol 2009;154:481–488. doi: 10.1007/s00705-009-0335-7.
74. Kamili S, Spelbring J, Carson D, Krawczynski K. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J Infect Dis 2004;189:258–264. doi: 10.1086/380801.
75. Kamili S, Spelbring J, Krawczynski K. DNA vaccination against hepatitis E virus infection in cynomolgus macaques. J Gastroenterol Hepatol 2002;17 Suppl 3:S365–S369. doi: 10.1046/j.1440-1746.17.s3.29.x.
76. Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine 2009;27:1032–1039. doi: 10.1016/j.vaccine.2008.11.097.
77. Taherkhani R, Farshadpour F, Makvandi M. Design and production of a multi-epitope construct derived from hepatitis E virus capsid protein. J Med Virol 2015;87:1225–1234. doi: 10.1002/jmv.24171.
78. Wu T, Li SW, Zhang J, Ng MH, Xia NS, Zhao Q. Hepatitis E vaccine develop-ment: a 14 year odyssey. Hum Vaccin Immunother 2012;8:823–827. doi: 10.4161/hv.20042.
79. Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009;27:1869–1874. doi: 10.1016/j.vaccine.2008.12.061.
80. Zhang J, Shih JW, Wu T, Li SW, Xia NS. Development of the hepatitis E vaccine: from bench to field. Semin Liver Dis 2013;33:79–88. doi: 10.1055/s-0033-1338116.
81. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895–902. doi: 10.1016/S0140-6736(10)61030-6.
82. Abbas Z, Afzal R. Hepatitis E: when to treat and how to treat. Antivir Ther 2014;19:125–131. doi: 10.3851/IMP2705.
83. Nijskens CM, Pas SD, van der Eijk AA, de Man RA. Hepatitis E in Europe: diagnosis and treatment. EMJ Gastroenterol 2015;4:121–127.
84. Debing Y, Neyts J. Antiviral strategies for hepatitis E virus. Antiviral Res 2014; 102:106–118. doi: 10.1016/j.antiviral.2013.12.005.
85. Peters van Ton AM, Gevers TJ, Drenth JP. Antiviral therapy in chronic hepatitis E: a systematic review. J Viral Hepat 2015;22:965–973. doi: 10.1111/jvh. 12403.